Company intelligence / Profile preview

Timik Group

Lillestrøm, Norway

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Timik Group is a specialized Nordic medical technology and pharmaceutical distribution company headquartered in Norway. The company focuses on providing high-quality medical devices and services in areas such as diabetes, respiratory care, and critical care across Sweden, Norway, Denmark, and Finland. Timik Group acts as a strategic partner for international manufacturers, handling regulatory compliance, marketing, and technical support for advanced healthcare products. In April 2024, the company was acquired by the Swedish industrial group Indutrade to strengthen its life sciences portfolio.

Therapeutic areas: EndocrinologyPulmonologyOther
Modalities: DeviceSmall molecule
Industry: Non-Academic Healthcare

Partnerships

DexcomTandem Diabetes CareInsulet

Beyond the preview

Go deeper on Timik Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Timik Group.

Explore the full profile